Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in QS over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. The inform ...

Question-and-Answer SessionWilliam NanceGoldman Sachs Group, Inc., Research Division Okay. So look, just to kick things off, the last 4 to 5 years have been a bit of a journey. You have continued to grow the customer base very consistently across both the accounts payable and the spend and expense side of the business. ARPU dynamics have been much more choppy. And I would say that's largely due to the macro dynamic we've seen spending pullbacks across the customer base as well as some of the monetization tr ...

Question-and-Answer SessionMaybe just to commence proceedings, we've got a couple of macro questions here we've been asking all our companies. But the first one is with China's rise in biotech innovation, how are you thinking about Immunocore's competitive position here? And will this influence your R&D and business development strategy?Travis CoyCFO, Executive VP & Head of Corporate Development Yes. First of all, Sean, thank you for having us. We appreciate it. China, it's interesting. They've made great s ...

Oxford Industries, Inc. OXM shares are trading higher after the company released its second-quarter results after Wednesday's closing bell. Here's a look at the key figures from the quarter. The Details: Oxford Industries reported quarterly earnings of $1.26 per share which beat the analyst estimate of $1.18.Quarterly revenue came in $403.14 million which missed the consensus estimate of $410.850 million. Read Next: UnitedHealth Stock Climbs On Reaffirmed Guidance: Details Oxford Industries reported the fol ...

(Bloomberg) -- Deutsche Bank AG’s US distressed-products desk notched more than $100 million in profit this year betting on securities affected by the dramatic near bankruptcy and subsequent windfall at Charlie Ergen’s EchoStar Corp., according to people familiar with the situation, who asked not to be named discussing confidential information. The unit traded and took positions in both equity and debt throughout EchoStar’s various units, the people said, getting a major lift in recent weeks after EchoSta ...

The funding covers more than half of the A.I. data centers that OpenAI plans to build in the U.S. over the next several years. ...

Artisan Partners Asset Management (NYSE:APAM) announced on Wednesday that its preliminary AUM totaled $178.1B as of August 31. This compares with the preliminary AUM of $175.0B at July 31. For August-end, Artisan Funds and Artisan Global Funds accounted for $87.0B. Separate accounts and ...

HIGH POINT, N.C.--(BUSINESS WIRE)--Culp, Inc. (NYSE: CULP), a leading provider of fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furniture and other applications, today reported financial and operating results for its first fiscal quarter ended August 3, 2025. Fiscal 2026 First Quarter Financial Highlights Continued market softness and a tariff-driven pause in residential upholstery shipments from China drove consolidated net sales of $50.7 million durin. ...

SAN DIEGO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on September 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 62,475 shares of its common stock and granted an aggregate of 43,800 restricted stock unit (“RSU”) awards to 20 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2 ...

Vancouver, British Columbia--(Newsfile Corp. - September 10, 2025) - Vizsla Royalties Corp. (TSXV: VROY) (OTCQB: VROYF) ("Vizsla Royalties" or the "Company") is pleased to announce the appointment of Matt Dugaro as an independent director of the Company, effective immediately.Mr. Dugaro brings more than 20 years of experience in mining investment banking, advising on corporate strategy, identifying, evaluating and executing mergers and acquisitions, and raising debt and equity capital. His track record has ...